Virtus ETF Advisers LLC Evelo Biosciences, Inc. Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.46 - $3.55 $30,678 - $74,596	-21,013 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.66 - $6.63 $3,309 - $8,247	-1,244 Reduced 5.59%	21,013 $71,000
Q4 2021 Feb 14, 2022	BUY	$6.07 - $12.0 $56,123 - $110,952	9,246 Added 71.06%	22,257 $135,000
Q3 2021 Nov 15, 2021	SELL	$6.79 - $13.9 $4,610 - $9,438	-679 Reduced 4.96%	13,011 $92,000
Q2 2021 Aug 10, 2021	BUY	$9.43 - $16.6 $129,096 - $227,254	13,690 New	13,690 $188,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.